Applications controlled release devices

Polylactic acid (PLA) has been produced for many years as a high-value material for use in medical applications such as dissolvable stitches and controlled release devices, because of the high production costs. The very low toxicity and biodegradability within the body made PLA the polymer of choice for such applications. In theory PLA should be relatively simple to produce by simple condensation polymerization of lactic acid. Unfortunately, in practice, a competing depolymerization process takes place to produce the cyclic lactide (Scheme 6.10). As the degree of polymerization increases the rate slows down until the rates of depolymerization and polymerization are the same. This equilibrium is achieved before commercially useful molecular weights of PLA have been formed. 

Initial tests in the rat revealed a high degree of tissue compatibility of Dat-Tyr-Hex derived polymers. More detailed tests are now in progress. In addition, tyrosine derived polymers are currently being evaluated in the formulation of an intracranial controlled release device for the release of dopamine, in the design of an intraarterial stent (to prevent the restenosis of coronary arteries after balloon angioplasty), and in the development of orthopedic implants. The use of tyrosine derived polymers in these applications will provide additional data on the biocompatibility of these polymers. 

This contribution will provide a review of polylectrolytes as biomaterials, with emphasis on recent developments. The first section will provide an overview of methods of synthesizing polyelectrolytes in the structures that are most commonly employed for biomedical applications linear polymers, crosslinked networks, and polymer grafts. In the remaining sections, the salient features of polyelectrolyte thermodynamics and the applications of polyelectrolytes for dental adhesives and restoratives, controlled release devices, polymeric drugs, prodrugs, or adjuvants, and biocompatibilizers will be discussed. These topics have been reviewed in the past, therefore previous reviews are cited and only the recent developments are considered here. 

We described reservoir capacity as the ability to contain an active ingredient within a matrix. In this sense, we give the term active ingredient the broadest possible meaning. We will show how polyurethanes are used to absorb exudates from deep tissue wounds. The exudates are considered active ingredients. We likened reservoir capacity to a bottle and controlled release to a bottle with a leak. A polyurethane can serve as a controlled release device, and we will illustrate this in a number of applications. 

Functionalized polymers are of interest in a variety of applications including but not limited to fire retardants, selective sorption resins, chromatography media, controlled release devices and phase transfer catalysts. This research has been conducted in an effort to functionalize a polymer with a variety of different reactive sites for use in membrane applications. These membranes are to be used for the specific separation and removal of metal ions of interest. A porous support was used to obtain membranes of a specified thickness with the desired mechanical stability. The monomer employed in this study was vinylbenzyl chloride, and it was lightly crosslinked with divinylbenzene in a photopolymerization. Specific ligands incorporated into the membrane film include dimethyl phosphonate esters, isopropyl phosphonate esters, phosphonic acid, and triethyl ammonium chloride groups. Most of the functionalization reactions were conducted with the solid membrane and liquid reactants, however, the vinylbenzyl chloride monomer was transformed to vinylbenzyl triethyl ammonium chloride prior to polymerization in some cases. The reaction conditions and analysis tools for uniformly derivatizing the crosslinked vinylbenzyl chloride / divinyl benzene films are presented in detail. 

Poly(vinylbenzyl chloride) (VBC) is an ideal starting material onto which a variety of functional groups can be attached through relatively simple reactions and mild reaction conditions. Functionalized polymers are of interest in a variety of applications including but not limited to fire retardants, selective sorption resins, chromatography media, controlled release devices and phase transfer catalysts. An example of the wide applicability of functionalized polymers is provided by trimethyl ammonium functionalized poly(VBC). 

Major polymer applications hot-melt coatings, hot-melt adhesives, wall covering adhesives, paints, tubing, sporting goods, footwear, baby products, controlled release devices, wire and cable (semiconductor shields, automotive wire, automotive ignition, low-smoke cable), asphalt modification, slow burning candles, cap liners... 

Mastromatteo, M., Mastromatteo, M., Conte, A., and Del Nobile, M.A. 2010. Advances in controlled release devices for food packaging applications. Trends Food Sci. Technol. 21 591-598. 

From lubricant applications to controlled released devices, the progress in stearic acid and derivatives are considered as challenging and groundbreaking. Future innovations in stearic acid-based lubricants could lead to the development of high-tech pharmaceutical excipients and devices which improve the production of pharmaceutical dosage forms. 

Electrochromic devices, where a transparent window can be turned opaque at selected regions of the electromagnetic spectrum under a potential, are another area in which PA copolymers and substituted PAs may have potential applications. Promising research opportunities also exist in the fabrication of PA-based controlled-release devices, non-linear optical devices, light-emitting diodes, and radar shielding. The readers are encouraged to consult some older [191-196] and more recent [197-199] review articles on these subjects. 

The diffusion-controlled devices outlined above are permanent, in that the membrane or matrix of the device remains in place after its delivery role has been completed. In applications in which the controlled release device is an implant, the drug-depleted device shell must be removed after use. This is undesirable such applications require a device that degrades during or after completion of its delivery role. 

Polyurethane hydrogels are widely used in soft contact lenses, controlled release devices, semipermeable membranes and hydrophilic coatings (66). The properties of polyurethane hydrogels can be varied by variation of their components, such as the polyols, diisocyanate, chain extender, or cross-linker (67-69). Because of the excellent mechanical and physical properties, polyurethanes are widely used in medical applications such as coating for medical devices for preventing protein adsorption (70, 71). 

---